Botulinum toxin as a hair loss treatment

Phase 4

Completed

• Conditions: Androgenetic alopecia; Skin - Dermatological conditions; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12613000821796
• Lead Sponsor: Paul Nola

Brief Summary

o benefit shown.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-25
• Study Completion: 2013-07-31
• Last Update Posted: 18 October 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Men and women with androgenetic alopecia who have not changed their hair loss treatment in the preceding three months.

Exclusion Criteria

Recent change (last three months) of hair loss treatment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hair bulk as measured with Haircheck device[Six months]

Secondary Outcome Measures

Name	Time	Method
one[None]